|
|
News Breaks
|
January 18, 2012
|
| 06:30 EDT |  | AUXL |
| theflyonthewall.com: | Auxilium upgraded to Outperform from Sector Perform at RBC Capital | | RBC Capital upgraded Auxilium citing favorable risk/reward into Ph III Peyronie data, low expectations for the Xiaflex business, and new management. Price target raised to $26 from $20. :theflyonthewall.com |
|
|
News For AUXL From The Last 14 Days Check below for free stories on AUXL the last two weeks.
There are 11 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
May 22, 2012
|
| 09:38 EDT |  | AUXL |
| theflyonthewall.com: | Auxilium upgraded to Buy from Neutral at MKM Partners (pre-open) | | :theflyonthewall.com |
|
|
May 21, 2012
|
| 07:04 EDT |  | AUXL |
| | 07:03 EDT |  | AUXL |
| theflyonthewall.com: | Auxilium raises FY12 global Testim revenue to $225M-$235M from $215M-$225M | | :theflyonthewall.com |
| | 07:03 EDT |  | AUXL |
| | 07:02 EDT |  | AUXL |
| theflyonthewall.com: | Auxilium, GlaxoSmithKline enter co-promotion agreement for Testim | | Auxilium (AUXL) and GlaxoSmithKline LLC, the U.S. subsidiary of GlaxoSmithKline (GSK), announced that they have entered into an agreement for the co-promotion of Testim 1%, which is indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of testosterone. :theflyonthewall.com |
|
|
May 17, 2012
|
| 07:01 EDT |  | AUXL |
|
|
May 14, 2012
|
| 08:00 EDT |  | AUXL |
|
|
May 11, 2012
|
| 13:11 EDT |  | AUXL |
| | 07:50 EDT |  | AUXL |
|
|
May 10, 2012
|
| 07:01 EDT |  | AUXL |
|
|
May 9, 2012
|
| 07:04 EDT |  | AUXL |
|
|
|
|
|